Crinetics Pharmaceuticals
CRNX
$41.51
Share price
-7.49%
Change (1 day)
126.34%
Change (1 year)
Categories
Earnings for Crinetics Pharmaceuticals (CRNX)
Earnings in 2023 (TTM): -$0.22 B
According to Crinetics Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.24 B. In 2022 the company made an earning of -$0.17 B a decrease over its 2021 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Crinetics Pharmaceuticals from 2017 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.22 B | 30.88% |
| 2022 | -$0.17 B | 52.28% |
| 2021 | -$0.11 B | 45.83% |
| 2020 | -$73.82 M | 46.39% |
| 2019 | -$50.43 M | 85.96% |
| 2018 | -$27.12 M | 196.11% |
| 2017 | -$9.16 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -51.55% | 🇺🇸 USA |